• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1997 Fiscal Year Final Research Report Summary

Biological significance of Prolinerich antimicrobial peptide

Research Project

Project/Area Number 08044228
Research Category

Grant-in-Aid for international Scientific Research

Allocation TypeSingle-year Grants
SectionJoint Research
Research Field 内科学一般
Research InstitutionAsahikawa Medical College

Principal Investigator

KOHGO Yutaka  Asahikawa Medical College, Medicine Professor, 医学部, 教授 (10133183)

Co-Investigator(Kenkyū-buntansha) FUJIMOTO Yoshinori  Asahikawa Medical College, Medicine, Instructor, 医学部, 助手 (90292127)
ASHIDA Tomofumi  Asahikawa Medical College, Medicine, Instructor, 医学部, 助手 (50261409)
YOKOTA Kinichi  Asahikawa Medical College, Medicine, Lecturer, 医学部, 講師 (10250573)
RICHARD Gall  ハーバード大学, 医学部, Assistant
ONO Minoru  Asahikawa Medical College, Medicine, Lecturer, 医学部, 講師 (60185650)
GALLO Richard  Harvard University, Medicine, Assistant Professor
Project Period (FY) 1996 – 1997
Keywordsantimicrobial peptide / PR-39 / syndecan / metastasis / cytoskeletone / ras sinal
Research Abstract

We clarified several important points about syndecans and PR-39 through colaborations and discussions with Dr.Gallo as shown below.
1.We made polyclonal antibody against PR-39 afer immunization of rabbits using N-terminal 15 aminoacids oigopeptides.
2.We observed the band at the size of approximately 5 kDa as expected size of PR-39 mature protein afer immunoprecipitation of human leukocytes protein using PR-39 polyclonal antibody. However, we have not cloned the protein which might be human counterpart of pig PR-39.
3.PR-39 has a possible function which can bind to Src homology 3 domain, becaus PR-39 has five repeats of proline rich motif that has been reported to bind SH3 domain as like a Sos protein which can bind to Grb2 protein. Recombinant SH3 domain of Src gene can actually bind to PR-39 oligopeptides by the study of immunopregipitation.
4.PR-39 gene transfection into human hepatoma cells showed induction of syndecan-1 expression, suppression of invasive activity and cell morphological change. These results might be due to the binding ability of PR-39 into SH3 domain.
5.PR-39 transfectans excreted PR-39 protein into conditioning medium.
6.PR-39 gene transfection into ras transformants also showed morphological change and decrease of proliferation rate.

  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] Matsumoto A: "Ruduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential." Int. J. Cancer. 74. 482-491 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 藤本 佳範: "syndecan-1およびその発現誘導因子PR-39の遺伝子導入による肝癌細胞の転移・浸潤能力低下について" Biotherapy. 11. 969-972 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 藤本 佳範: "肝癌細胞の再発・転移におけるsyndecan-1の発現低下について-syndecan-1およびその発現誘導因子PR-39の遺伝子導入による再発・転移阻止を目的とした遺伝子治療の試み-" 消化器癌の発生と進展. 9. 61-64 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 高後 裕: "syndecan-1の発現低下と転移" 肝胆膵. 34. 165-171 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Matsumoto A: "Ruduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential." Int.J.Cancer. 74. 482-491 (1997)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi